CURE241220C120000
- 0.73
- 0.000.00%
Direxion Daily Healthcare Bull 3X Shares Newsroom
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Merck Recommends Rejection Of TRC Capital's "Mini-Tender" Offer To Purchase Up To 1M Shares Of Common Stock At $96.38 Per Share
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Market Climbs, Bitcoin Close to $100k | Live Stock
This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and Others
AbbVie Analyst Ratings
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Zevra Niemann-Pick Disease Type C Drug Miplyffa Now Available
Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are...
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade